Public And Private Payer Perspectives On The Net Cost Of Implementation Of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Compared With 7-Valent Pneumococcal Conjugate Vaccine (PCV7) To In The United States
Abstract
Authors
M. Kohli M. Maschio R.A. Farkouh L. McGarry D.R. Strutton M.C. Weinstein